Utilizing questionnaires for medication counselling of patients taking antipsychotics during the COVID-19 pandemic: a single site, community pharmacy-based survey study

• Published in: Journal of pharmaceutical health care and sciences Vol. 8; no. 1; p. 34
• Main Authors: Maehara, Masaki, Sugiyama, Masayasu
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 07.12.2022; BioMed Central; BMC
• Subjects: Antipsychotic drugs; Antipsychotics; Communicable diseases; Communication; Community pharmacy; Coronaviruses; Counseling; COVID-19; Drug stores; Drugs; Epidemics; Health counseling; Infectious diseases; Japan; Medication counselling; Mental disorders; Patient compliance; Patient education; Patient satisfaction; Pharmacists; Pharmacy; Prevention; Questionnaires; Safety equipment; Severe acute respiratory syndrome coronavirus 2; Sexual disorders; Surveys; Japan; COVID-19; Medication counselling; Community pharmacy
• ISSN: 2055-0294; 2055-0294
• DOI: 10.1186/s40780-022-00263-w

During the coronavirus disease (COVID-19) pandemic, general strategies for preventing infectious diseases, such as social distancing and the use of protective equipment have resulted in communication barriers between pharmacists and patients in community pharmacies. To resolve these communication challenges to medication counselling during the COVID-19 pandemic, during their waiting time at our community pharmacy, we administered two questionnaires to patients receiving at least one antipsychotic drug. The first questionnaire, Questionnaire (A), included questions about any problems with wearing a mask and face shield, forgetting to take medication and adverse effects of their medication. The second questionnaire, Questionnaire (B), included questions regarding the evaluation of medication counselling and the ease of using the first questionnaire. Questionnaire (A) showed that 26.8% of participants had communication problems due to the mask and face shield and 33.8% sometimes forgot to take their medication. The most common adverse effects of the medications were weight gain (43.7%), dry mouth (39.4%) and sexual dysfunction (31%). In the case of Questionnaire (B), more than 80% responded that it was either very easy or easy to fill out Questionnaire (A). Additionally, 93% participants responded that they felt either very good or good about the pharmacist's medication counselling using Questionnaire (A). These results strongly suggest that the utilization of questionnaires in medication counselling may be a useful strategy for preventing communication problems between pharmacists and patients receiving antipsychotics in community pharmacies during and after the COVID-19 pandemic.